Free Trial

Auna (AUNA) Competitors

$8.43
-0.29 (-3.33%)
(As of 05/20/2024 ET)

AUNA vs. LFMD, TVTX, EHAB, TSHA, OFIX, VYGR, WGS, FULC, KALV, and ALEC

Should you be buying Auna stock or one of its competitors? The main competitors of Auna include LifeMD (LFMD), Travere Therapeutics (TVTX), Enhabit (EHAB), Taysha Gene Therapies (TSHA), Orthofix Medical (OFIX), Voyager Therapeutics (VYGR), GeneDx (WGS), Fulcrum Therapeutics (FULC), KalVista Pharmaceuticals (KALV), and Alector (ALEC). These companies are all part of the "medical" sector.

Auna vs.

Auna (NYSE:AUNA) and LifeMD (NASDAQ:LFMD) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, earnings, risk, community ranking, institutional ownership, profitability and dividends.

In the previous week, Auna had 4 more articles in the media than LifeMD. MarketBeat recorded 6 mentions for Auna and 2 mentions for LifeMD. LifeMD's average media sentiment score of 0.48 beat Auna's score of 0.39 indicating that LifeMD is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Auna
0 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
LifeMD
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

35.5% of LifeMD shares are held by institutional investors. 18.9% of LifeMD shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

LifeMD received 22 more outperform votes than Auna when rated by MarketBeat users. However, 100.00% of users gave Auna an outperform vote while only 70.27% of users gave LifeMD an outperform vote.

CompanyUnderperformOutperform
AunaOutperform Votes
4
100.00%
Underperform Votes
No Votes
LifeMDOutperform Votes
26
70.27%
Underperform Votes
11
29.73%

Auna has higher revenue and earnings than LifeMD.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Auna$3.88B0.16N/AN/AN/A
LifeMD$152.55M2.19-$20.60M-$0.74-10.68

Auna presently has a consensus price target of $14.15, suggesting a potential upside of 67.85%. LifeMD has a consensus price target of $11.60, suggesting a potential upside of 46.84%. Given Auna's higher probable upside, research analysts clearly believe Auna is more favorable than LifeMD.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Auna
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
LifeMD
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

Auna has a net margin of 0.00% compared to LifeMD's net margin of -14.75%.

Company Net Margins Return on Equity Return on Assets
AunaN/A N/A N/A
LifeMD -14.75%N/A -49.23%

Summary

Auna and LifeMD tied by winning 6 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AUNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AUNA vs. The Competition

MetricAunaOffices & clinics of medical doctors IndustryMedical SectorNYSE Exchange
Market Cap$623.13M$749.19M$5.02B$17.98B
Dividend YieldN/AN/A45.43%3.43%
P/E RatioN/A35.92160.9425.83
Price / Sales0.161.192,490.5710.89
Price / CashN/A73.0132.6015.96
Price / BookN/A10.005.025.18
Net IncomeN/A-$189.18M$102.68M$973.94M
7 Day Performance-5.07%8.52%1.65%1.63%
1 Month Performance23.97%-2.57%5.60%6.56%
1 Year PerformanceN/A18.13%7.26%23.64%

Auna Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFMD
LifeMD
1.5889 of 5 stars
$9.32
+0.2%
$11.60
+24.5%
+280.9%$508.65M$152.55M-13.31207High Trading Volume
TVTX
Travere Therapeutics
0.956 of 5 stars
$6.30
-4.5%
$16.69
+165.0%
-63.2%$498.51M$145.24M-3.00380
EHAB
Enhabit
2.996 of 5 stars
$8.33
+0.5%
$11.21
+34.6%
-30.6%$494.54M$1.05B-5.1410,800High Trading Volume
TSHA
Taysha Gene Therapies
2.102 of 5 stars
$2.34
-7.5%
$6.88
+193.8%
+317.8%$489.99M$15.45M-3.4952Earnings Report
Analyst Revision
OFIX
Orthofix Medical
0.5275 of 5 stars
$14.64
+1.0%
$18.00
+23.0%
-24.5%$503.49M$746.64M-3.541,634
VYGR
Voyager Therapeutics
3.8021 of 5 stars
$8.44
flat
$19.60
+132.2%
-36.0%$486.23M$250.01M2.73162Analyst Revision
WGS
GeneDx
1.4937 of 5 stars
$20.75
+2.1%
$18.00
-13.3%
+245.0%$509.91M$202.57M-4.011,000Positive News
Gap Down
FULC
Fulcrum Therapeutics
2.7279 of 5 stars
$7.47
-0.4%
$13.17
+76.3%
+132.3%$481.69M$2.81M-4.7376Analyst Forecast
Gap Up
KALV
KalVista Pharmaceuticals
4.0399 of 5 stars
$12.08
-0.1%
$25.00
+107.0%
+13.2%$512.17MN/A-3.83118
ALEC
Alector
3.5044 of 5 stars
$5.25
+1.0%
$14.00
+166.7%
-28.3%$512.77M$97.06M-3.39244

Related Companies and Tools

This page (NYSE:AUNA) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners